Market Insights:
The global single-use bio-processing systems market is expected to witness significant growth during the forecast period, driven primarily by the growing demand and cost-effective features of these single-use systems, which are mostly used in R&D applications. The essential bio-processing systems used in R&D applications are disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and probes and sensors. The overall market has also undergone a paradigm shift owing to the growing usage of GMP single-use systems and the increasing outsourcing of activities to developing nations.
The prime factors driving the market are the adoption of cost-cutting practices by biopharmaceutical companies and the increasing prevalence of diseases leading to the procurement of biologics and biopharmaceuticals. Asia Pacific is expected to grow at the highest rate during the forecast period due to the increasing adoption of single-use bio-processing systems, the rise in healthcare spending, and the increase in outsourcing activities by biopharmaceutical vendors based in the developed region.
The report titled “Single-use Bio-processing Systems Market: Growth, Share, Opportunities, and Competitive Analysis, 2016–2023” offers strategic insights into the overall single-use bio-processing systems market, along with the market size and estimates for the duration of 2016–2023. The said research study covers an in-depth analysis of multiple market segments based on the type of application and different geographical regions.
The application type segments studied for analyzing the overall single-use bioprocessing systems market are R&D support single-use systems and GMP single-use systems. In order to help strategic decision-makers, the report also includes competitive profiling of the leading players in the single-use bio-processing systems market, an attractive investment proposition, Porter’s five forces model, and the market positioning of key manufacturers. Other in-depth analysis provided in the report includes:
Geographically, the single-use bio-processing systems market is studied for the following regional markets:
- North America
- Europe
- Germany
- France
- Italy
- U.K.
- Russia
- Rest of Europe
- Asia-Pacific
- India
- China
- Japan
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of Middle East and Africa
The market size and forecast for these regional and country-level markets are presented in this study for the period 2013–2023. Market growth rates for the forecast period 2016–2023 are also included in this report, considering 2015 as the base year.
Along with quantitative information, qualitative information sets and assessment tools are provided in this study for a better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges, and opportunities assists the readers in understanding the ongoing trends in the global single-use bioprocessing systems market. Tools such as the market positioning of key players and an attractive investment proposition provide the readers with insights into the competitive scenario of the global single-use bioprocessing systems market. This report concludes with a company profiles section that highlights major information about the key players engaged in the single-use bio-processing systems market. In-depth competitive environment analysis and historical years’ (2013 and 2014) market size data are also provided in the report.
Thus, the research study provides a holistic view of the global single-use bioprocessing systems market, offering market size and estimates for the period from 2016 to 2023, keeping in mind the above-mentioned factors.
Based on the applications, the global single-use bio-processing systems market is segmented as follows:
- R&D Support for Bioprocessing Systems
- GMP single-use bioprocessing systems
Single-use bioprocessing technology is a rapidly evolving technology that focuses on developing disposable bioprocess equipment and accessories for manufacturing the desired products. The goal of these systems is to reduce the costs associated with complex steps such as sterilization, cleaning, and maintenance of steel-based bioreactor systems and accessories. The current single-use bioprocessing systems include disposable bioreactors, mixers, containers, tubing, connectors, sampling systems, purification devices and columns, and probes and sensors. The global single-use bioprocessing systems market is broadly classified into two segments: R&D support single-use systems and GMP single-use systems.
The R&D support laboratories adopt single-use systems for optimizing the development of biologics and biopharmaceuticals. They are also used by research centers and academic institutions to reduce the long sterilization process and simplify the research. The GMP single-use systems are employed by biopharmaceutical companies and other biomanufacturing companies to reorient their business and manufacturing processes. The R&D Support, Single-use Systems segment held the largest share in the global single-use bioprocessing systems market. The market is driven primarily by the growing demand and cost-effective features of these single-use systems, which are mostly used in R&D applications.
For the purpose of this study, the global single-use bio-processing system market is categorized as follows:
- North America
- Europe
- Asia Pacific
- Latin America (LATAM)
- Middle East and Africa
The geographical segmentation of the global single-use bioprocessing system market comprises North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. In the base year of 2015, North America accounted for the largest market in the single-use bioprocessing system market due to the adoption of cost-cutting practices by biopharmaceutical companies.
Moreover, the increasing prevalence of diseases has favored the procurement of biologics and biopharmaceuticals. However, currency fluctuations, fluctuations in the price of raw materials, and stringent regulations are expected to limit the growth of this market during the forecast period. Asia Pacific is expected to grow at the highest rate during the forecast period due to the increasing adoption of single-use bio-processing systems, the rise in healthcare spending, and the increase in outsourcing activities by biopharmaceutical vendors based in the developed region.
